Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1152/week)
Manufacturing
(556/week)
Energy
(457/week)
Technology
(1067/week)
Other Manufacturing
(350/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Amyloid beta
Mar 22, 2019
Initiation Of Phase III Clinical Trial Of BAN2401 In Early Alzheimer's Disease
Mar 21, 2019
BioArctic's Partner Eisai Initiates the Confirmatory Phase 3 Study of BAN2401 in Early Alzheimer's Disease
Mar 21, 2019
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease
Mar 15, 2019
ProMIS Neurosciences Announces Fiscal Year 2018 Annual Results
Mar 08, 2019
World Alzheimer Disease Markets, 2018-2019 & 2028 with Profiles of 116 Companies with 82 Collaborations
Mar 07, 2019
BioArctic: Eisai Announces Timelines for the Single Confirmatory Phase 3 Study With BAN2401 in Warly Alzheimer's Disease
Feb 21, 2019
ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors
Feb 05, 2019
McCord Research Identifies Olive Compounds that May Act Against Alzheimer's Disease
Jan 31, 2019
Selectivity for the Toxic Oligomer Essential to Treating Root Cause of Alzheimer's Disease
Jan 17, 2019
ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences
Jan 16, 2019
United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease
Dec 18, 2018
ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek
Dec 17, 2018
ProMIS Neurosciences Appoints Renowned Neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board
Dec 07, 2018
New Generation of Therapeutics Based on Understanding of Aging Biology Show Promise for Alzheimer's Disease
Nov 26, 2018
Never-before-seen DNA recombination in the brain linked to Alzheimer's disease
Nov 20, 2018
ProMIS Neurosciences Issues Year-to Date Update, Highlighting 2018 Accomplishments
Nov 13, 2018
ProMIS Neurosciences Announces Third Quarter 2018 Results
Nov 06, 2018
ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer's Disease
Oct 31, 2018
ProMIS Neurosciences Identifies Novel Targets on Tau Protein Involved in the Development of Alzheimer's Disease and Other Dementias
Oct 30, 2018
HKBU's New Nanomaterial Could Enable Early Detection and Diagnosis of Alzheimer's Disease
‹‹
Page 2
››
Latest News
Jul 19, 2025
Delek Logistics Partners, LP to Host Second Quarter 2025 Conference Call on August 6th
Jul 19, 2025
Delek US Holdings to Host Second Quarter 2025 Conference Call on August 6th
Jul 19, 2025
Mesa Royalty Trust Announces Trust Income for July 2025
Jul 19, 2025
Permianville Royalty Trust Announces Monthly Operational Update
Jul 19, 2025
Comfort Systems USA Announces Second Quarter 2025 Conference Call and Webcast
Jul 19, 2025
Ampco-Pittsburgh Corporation Issues Reminder Regarding Warrant Expiration
Jul 19, 2025
ConocoPhillips Makes Application to Cease to Be a Reporting Issuer in Canada
Jul 19, 2025
Xcel Energy Announces Portfolio of New Power Projects to Meet Growing Demand in Texas and New Mexico
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events